A Cutting-Edge Cancer Treatment Is Under FDA Investigation—for Cancer Risk

CAR-T cell therapy harnesses the immune system to attack blood cancers. Six years after approving the first treatment, the FDA is investigating whether it can give rise to secondary cancers.

from Feed: All Latest https://ift.tt/ZrfD9Oj
via IFTTT

No comments:

Post a Comment

CES 2025: Garmin Launches Its Instinct 3 Series With Screen Upgrades and Built-In Flashlights

Garmin produces more variations on the smartwatch theme than anyone else, and the Instinct series is the range that prioritizes battery life...